Abstract
The described labelling and purification preparation of N-isopropyl-p-131I-amphetamine /131I-IMP/ represents a fast and efficient method to obtain a compound that fulfils all criteria of purity for its in-vivo application. After isotope exchange and quality control131I-IMP could be obtained with radiochemical yields in the range between 68% and 78% with a radiochemical purity of 98–99%. As demonstrated in animal experiments the cerebral affinity of IMP offers a possibility for the diagnosis of brain diseases in clinical studies when the product is labelled with123I.
Similar content being viewed by others
References
H.S. Winchell, R.M. Baldwin, T.H. Lin,J. Nucl. Med., 21 /1980/ 940.
T. Sargent, U. Braun, G. Braun,J. Nucl. Med., 19 /1978/ 72.
H. S. Winchell, W.D. Horst, L. Braun, W.H. Oldendorf, R. Hattner, H. Parker,J. Nucl. Med., 21 /1980/ 947.
M.B. Cohen, L.S. Graham, L.S. Yamada,Appl. Radiation Isotopes, 17 /1986/ 749.
B.L. Holman, T.C. Hill, R.G. Lee, R.E. Zimmerman, S.C. Moore, H.D. Royal. Brain Imaging with Radiolabelled Amines, in: Nuclear Medicine Annual /Eds by L.M. Freeman, H.S. Weissman/, Raven Press, New York, 1983, p. 131.
E.J. Knust, H.-J. Machulla, R.M. Baldwin, T. Chen, L.E. Feinendegen,Nuklearmedizin, 23 /1984/ 31.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Figols, M., Gonçalves, R.d.S.V., Muramoto, E. et al. Synthesis of N-isopropyl-p-123I-amphetamine and biodistribution in rats. Journal of Radioanalytical and Nuclear Chemistry Letters 136, 331–339 (1989). https://doi.org/10.1007/BF02164725
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02164725